Association of Gestational Cardiovascular Health With Pregnancy Outcomes

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age20-49
SponsorWomen's Hospital School Of Medicine Zhejiang University

About this trial

Pregnancy is a critical period for cardiovascular health risk assessment and interventions to reduce the incidence of cardiovascular disease in both mother and child generations. Recently, the American Heart Association proposed the latest cardiovascular health assessment indicator "Life's Essential 8". However, there is still a lack of application data for pregnant women. This project intends to explore the application potential of Life's Essential 8 in cardiovascular health assessment of pregnant women and establish appropriate gestaional cardiovascular health standards.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Maternal age: 20-49 years;

Natural conception;

Single pregnancy;

Plan to have routine prenatal examinations and give birth in the research center;

Disqualifiers

Have diseases that affect metabolic function or even threaten the life of the mother and fetus before pregnancy;

Assisted reproduction;

Multiple pregnancy;

Fetus has a known deformity or genetic defects;

Trial population

This project intends to recruit pregnant women who go to the research center for routine prenatal examination and give birth.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Questionnaire survey and specimen collection

    Other intervention

    Questionnaire survey, clinical follow-up and specimens collection.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Maternal outcomes

Including pregnancy-induced hypertension, preterm delivery, abortion, delivery way and so on. They are diagnosed by clinicians and the data is gathered from medical records.

Time frame
Through delivery completion, up to 42 weeks
2

Neonatal outcomes

Birth weight(in gram), birth height (in centimetre), gestational week (in week) and other neonatal diseases. They are diagnosed by clinicians and the data is gathered from medical records.

Time frame
Through delivery completion, up to 42 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.